$28.98
0.24% yesterday
NYSE, May 14, 10:01 pm CET
ISIN
US2289031005
Symbol
AORT

CryoLife Stock price

$28.98
+5.85 25.29% 1M
+1.99 7.37% 6M
+0.39 1.36% YTD
+5.54 23.63% 1Y
+11.74 68.10% 3Y
+7.41 34.35% 5Y
+18.61 179.46% 10Y
NYSE, Closing price Wed, May 14 2025
+0.07 0.24%
ISIN
US2289031005
Symbol
AORT
Sector

Key metrics

Market capitalization $1.24b
Enterprise Value $1.56b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.00
P/S ratio (TTM) P/S ratio 3.17
P/B ratio (TTM) P/B ratio 4.21
Revenue growth (TTM) Revenue growth 5.94%
Revenue (TTM) Revenue $390.08m
EBIT (operating result TTM) EBIT $24.84m
Free Cash Flow (TTM) Free Cash Flow $-440.00k
Cash position $37.69m
EPS (TTM) EPS $-0.51
P/E forward 259.52
P/S forward 2.90
EV/Sales forward 3.66
Short interest 10.62%
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a CryoLife forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a CryoLife forecast:

Buy
100%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
390 390
6% 6%
100%
- Direct Costs 156 156
8% 8%
40%
234 234
5% 5%
60%
- Selling and Administrative Expenses 157 157
37% 37%
40%
- Research and Development Expense 28 28
1% 1%
7%
49 49
39% 39%
12%
- Depreciation and Amortization 24 24
2% 2%
6%
EBIT (Operating Income) EBIT 25 25
56% 56%
6%
Net Profit -21 -21
123% 123%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Neutral
PRNewsWire
about 12 hours ago
ATLANTA , May 14, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it entered into separate, privately negotiated exchange agreements with certain holders of its 4.250% Convertible Senior Notes due 2025 (the "Existing Convertible Notes"). Under the exchange agreements, the company will, subject to cu...
Neutral
Seeking Alpha
9 days ago
Artivion, Inc. (NYSE:AORT ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Dorothy Morgan - Gilmartin Group LLC Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants John McAulay - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Kalia - Oppenheimer & Company Mike Matson - Needham & Company Daniel Stauter -...
Neutral
PRNewsWire
10 days ago
First Quarter Highlights: Achieved revenue of $99.0 million in the first quarter of 2025 versus $97.4 million in the first quarter of 2024, an increase of 2% on a GAAP basis and 4% on a non-GAAP constant currency basis Net loss was $(0.5) million, or $(0.01) per fully diluted share and non-GAAP net income was $2.5 million, or $0.06 per fully diluted share in the first quarter of 2025 Adjusted E...
More CryoLife News

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website www.artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today